|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2009-11-26
|
|
pubmed:abstractText |
Aspirin is effective in secondary prevention of cardiovascular disease. The results are less convincing when aspirin is used for primary prevention even in high-risk patients (i.e., patients with diabetes). We therefore analyzed the effect of aspirin on mortality and serious bleeding in diabetic patients with and without cardiovascular disease.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1099-1557
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright (c) 2009 John Wiley & Sons, Ltd.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1143-9
|
|
pubmed:meshHeading |
pubmed-meshheading:19672841-Age Factors,
pubmed-meshheading:19672841-Aged,
pubmed-meshheading:19672841-Aspirin,
pubmed-meshheading:19672841-Cardiovascular Diseases,
pubmed-meshheading:19672841-Diabetes Complications,
pubmed-meshheading:19672841-Female,
pubmed-meshheading:19672841-Gastrointestinal Hemorrhage,
pubmed-meshheading:19672841-Humans,
pubmed-meshheading:19672841-Male,
pubmed-meshheading:19672841-Medical Record Linkage,
pubmed-meshheading:19672841-Middle Aged,
pubmed-meshheading:19672841-Platelet Aggregation Inhibitors,
pubmed-meshheading:19672841-Secondary Prevention,
pubmed-meshheading:19672841-Sweden
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Aspirin increases mortality in diabetic patients without cardiovascular disease: a Swedish record linkage study.
|
|
pubmed:affiliation |
Department of Medicine, Lidköping Hospital, Lidköping, Sweden. lennart.x.welin@vgregion.se
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
